A Phase 1/2, Multi-center, Open-label Study of IMGN632 Monotherapy Administered Intravenously in Patients with CD123-positive Acute Myeloid Leukemia and Other CD123-positive Hematologic Malignancies
NOT ENROLLING
Trial ID:
NCT03386513 Protocol # :
18-013
Phase
I
Disease Sites
Other Hematopoietic
Myeloid and Monocytic Leukemia
Principal Investigator
DeAngelo, Daniel, J
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-013
18-013